Skip to content
Search

Latest Stories

GPhC launches consultation to boost equality, diversity, and inclusion

The General Pharmaceutical Council (GPhC) has started a consultation on its five-year strategy to deliver equality, improve diversity and foster inclusion.

The consultation is open until July 12 and seeks views on the proposals' impact on patients, the public, pharmacy professionals, and employers.


“The 12-week consultation seeks views on the GPhC’s proposals to be more proactive and joined up in using its regulatory influence and levers to help reform the structures and practices that maintain inequality and discrimination within pharmacy and pharmacy regulation,” the pharmacy regulator said in an update yesterday (April 20).

The strategy recognises that professional regulators, the public they serve and the professionals they regulate face many complex and important equality, diversity and inclusion challenges.

The strategy is also sets out three key themes to help transform the GPhC’s approach to equality, diversity and inclusion.

The GPhC’s three key themes are:

  • to make regulatory decisions that are demonstrably fair, lawful, and so free from discrimination and bias
  • to use our standards to proactively help tackle discrimination in all pharmacy settings and make sure everyone can access person-centred care, fostering equality of health outcomes, and
  • to lead by example and demonstrate best practice within our organisation, holding ourselves to the same high standards we expect of others.

GPhC chief executive Duncan Rudkin said:  “This strategy brings a new focus and energy to our efforts to progress how we deliver equality, improve diversity and foster inclusion.  It provides a framework for the delivery of this work, across our organisation, in support of our Vision 2030 and Strategic Plan 2020-2025.

“For this strategy to be effective, we will need to work collaboratively with our colleagues and stakeholders across pharmacy to make this happen.  We welcome views on our proposals to help us achieve our aims.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less